Back to search

United States· US:55910-306_8bac7057-0897-4019-9910-ca29e2a9d2d2

dg health clearlax

A medicinal product containing polyethylene glycol 3350, registered in United States by Dolgencorp, LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normaliseddg health clearlaxATC—REGISTER NO.US:55910-306_8bac7057…PACKS LISTED6CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
POLYETHYLENE GLYCOL 3350
Manufacturer
Dolgencorp, LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 6

  • ndc11
    5591030601
    119 g in 1 BOTTLE (55910-306-01)
  • ndc11
    5591030602
    238 g in 1 BOTTLE (55910-306-02)
  • ndc11
    5591030603
    510 g in 1 BOTTLE (55910-306-03)
  • ndc11
    55910-306-01
  • ndc11
    55910-306-02
  • ndc11
    55910-306-03

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Polyethylene glycol 3350 in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All polyethylene glycol 3350 products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Belgium · Transisoft
  • Germany · Transisoft
  • France · Transipeg, Transipeglib
  • United Kingdom (Northern Ireland) · Transisoft
  • Ireland · Transisoft
  • Italy · Transisoft

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d23549ec-632a-4157-affd-68598e69fe22
GET /v1/drugs/d23549ec-632a-4157-affd-68598e69fe22?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "17",
  "substance": "POLYETHYLENE GLYCOL 3350",
  "productndc": "55910-306",
  "dosage_form": "POWDER, FOR SOLUTION",
  "dea_schedule": null,
  "strength_unit": "g/17g",
  "application_number": "ANDA090685",
  "marketing_category": "ANDA"
}

See everything about polyethylene glycol 3350.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.